MD Analytics provides industry leading healthcare and pharmaceutical marketing research solutions. We’re driven by innovation and an unwavering customer focus, backed up by largest online panel of healthcare professionals.
Emphasizing the synergy between our quantitative and qualitative research methodologies, we work along side the industry’s top market research executives in pharmaceutical and healthcare organizations located in Toronto, Montreal and throughout Canada. Our highly specialized team of marketing research professionals brings together deep pharmaceutical marketing and healthcare experience with advanced market research and analytical proficiency, to deliver rich, actionable insights.
The work we do spans across all stages of a brand’s life cycle and includes research with physicians, other healthcare professionals and patients. A few typical applications, include: early stage market assessments, positioning research, advertising testing, awareness and usage tracking, segmentation, sales representative detail tracking, and custom research to meet specific needs. We also offer integrated marketing research solutions, such as our Pathways2Rx™ service, mapping out all the various pathways to treatment selection and usage, through a combination of qual/quant methodologies and secondary data to seek out new opportunities of untapped potential.
Aside from client driven projects we also produce insightful syndicated studies following new trends and policy decisions affecting pharmaceutical marketing and healthcare delivery decisions. These reports provide valuable insights on topics of interest to broader audiences. Examples of our syndicated studies, include following trends in pharmacists' prescribing, monitoring pharmaceutical rep access to physicians, and the changing preferences of physicians in continuing medical education.
At this point we invite you to please stay awhile to learn more about the work we do, and enjoy the news and stories we’ve put here for you.
In a recent syndicated study conducted by MD Analytics, 56% of physicians surveyed indicated they own a SmartPhone. Among users of SmartPhones, more than 1 in 5 “always” or “often” use the device as a diagnosis or treatment support tool: 20% before a patient consultation; 22% during a patient consultation; and 27% after a patient consultation.
MD Analytics conducts a wide variety of syndicated studies following industry trends and topical issues.
This innovative service offering fills a wide gap in currently available drug usage data both at the national and provincial level. This ongoing study is conducted using mobile devices at the point of care capturing treatment decisions while they are made, thereby providing superior accuracy.
To learn more about this service or to see a live demo of the data collection tool, please contact us.